Mumps is a contagious disease typically affecting children and caused by the mumps virus. The characteristic of this disease is the initial onset of headache, loss of appetite, muscle aches, tiredness and fever followed by the typical swelling of one or more salivary glands.
North America is expected to lead the mumps market, owing to higher rates of vaccination coupled with the expensive cost of vaccination and treatment.
The mumps market in Asia is anticipated to register the third spot after Europe, which is expected to take second largest share in the market during the forecast period.
In 2018, the global Mumps market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 20192025.
This report focuses on the global Mumps status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Mumps development in United States, Europe and China.
The key players covered in this study
Serum Institute of India
Market segment by Type, the product can be split into
Market segment by Application, split into
Market segment by Regions/Countries, this report covers
Central & South America
The study objectives of this report are:
To analyze global Mumps status, future forecast, growth opportunity, key market and key players.
To present the Mumps development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Mumps are as follows:
History Year: 20142018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.